Cancer Immunology, Immunotherapy has the basic aim of keeping readers informed of the latest research results in the fields of oncology and immunology. As knowledge expands, the scope of the journal has broadened to include more of the progress being made in the areas of biology concerned with biological response modifiers. This helps keep readers up to date on the latest advances in our understanding of tumor-host interactions.The journal publishes short editorials including "position papers," general reviews, original articles, and short communications, providing a forum for the most current experimental and clinical advances in tumor immunology.
Cancer Immunology, Immunotherapy的基本目标是让读者了解肿瘤学和免疫学领域的最新研究成果。随着知识的扩展，该杂志的范围已经扩大到包括更多与生物反应调节剂有关的生物学领域取得的进展。这有助于让读者了解我们对肿瘤-宿主相互作用理解的最新进展。该杂志发表简短的社论，包括“立场文件”、一般评论、原创文章和简短的交流，为最新的实验和肿瘤免疫学的临床进展。
Combining alpha radiation-based brachytherapy with immunomodulators promotes complete tumor regression in mice via tumor-specific long-term immune response
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02418-5
Mouse CD8+NKT-like cells exert dual cytotoxicity against mouse tumor cells and myeloid-derived suppressor cells
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02363-3
Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02304-0
Patterns of immune-cell infiltration in murine models of melanoma: roles of antigen and tissue site in creating inflamed tumors
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02345-5
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02458-x
Activation of dendritic cells by targeted DNA: a potential addition to the armamentarium for anti-cancer immunotherapy
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02400-1
Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02387-9
Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02414-9
T-cell recognition of non-mutated tumor antigens in healthy individuals: connecting endogenous immunity and tumor dormancy
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02335-7
PLAC1: biology and potential application in cancer immunotherapy
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02350-8
Immune-phenotyping of pleomorphic dermal sarcomas suggests this entity as a potential candidate for immunotherapy
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02339-3
Contribution of Fcγ receptor IIB to creating a suppressive tumor microenvironment in a mouse model
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02413-w
HCT-116 colorectal cancer cells secrete chemokines which induce chemoattraction and intracellular calcium mobilization in NK92 cells
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02319-7
Natural killer cells control metastasis via structural editing of primary tumors in mice
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02405-w
High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02362-4
Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02425-6
Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02316-w
ISG15 pathway knockdown reverses pancreatic cancer cell transformation and decreases murine pancreatic tumor growth via downregulation of PDL-1 expression
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02422-9
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02409-6
An HER2 DNA vaccine with evolution-selected amino acid substitutions reveals a fundamental principle for cancer vaccine formulation in HER2 transgenic mice
来源期刊：Cancer Immunology, ImmunotherapyDOI：10.1007/s00262-019-02333-9
